A Clinical observation of mifepristone for treatment of perimenopausal dysfunctional uterine bleeding
Jing Chang
Abstract
Jing Chang
Abstract
Objective To explore the clinical effect of mifepristone for treatment of perimenopausal dysfunctional uter ine bleeding.Methods Eighty-four patients of perimenopausal dysfunctional uterine bleeding were randomly divided into control group and observation group,with each groups of 42 patients,the control group were treated with 10 mg/d Medroxyprogesterone Acetate,the observation group were treated with 6.25 mg/d Mifepristone,follow up 3 months and evaluate the clinical efficacy of two groups.Results After treatment,the FSH、E2、LH and P level of two groups significantly decreased(P 0.05),and the observation group lower than control group(P 0.05);The improvement of endometrial thickness and uterus volume in observation group were significantly decreased than control group(P 0.05);The rate of adverse of control group was 19.05%,and observation group was 4.76%,there was significantly difference between two groups(P 0.05).Conclusion Treatment of perimenopausal dysfunctional uterine bleeding with mifepris tone is a safe and validity method,is worthy of promotion and application.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the clinical effect of mifepristone for treatment of perimenopausal dysfunctional uter ine bleeding.Methods Eighty-four patients of perimenopausal dysfunctional uterine bleeding were randomly divided into control group and observation group,with each groups of 42 patients,the control group were treated with 10 mg/d Medroxyprogesterone Acetate,the observation group were treated with 6.25 mg/d Mifepristone,follow up 3 months and evaluate the clinical efficacy of two groups.Results After treatment,the FSH、E2、LH and P level of two groups significantly decreased(P 0.05),and the observation group lower than control group(P 0.05);The improvement of endometrial thickness and uterus volume in observation group were significantly decreased than control group(P 0.05);The rate of adverse of control group was 19.05%,and observation group was 4.76%,there was significantly difference between two groups(P 0.05).Conclusion Treatment of perimenopausal dysfunctional uterine bleeding with mifepris tone is a safe and validity method,is worthy of promotion and application.
Key concepts: Medicine, Dysfunctional uterine bleeding, Mifepristone, Medroxyprogesterone acetate, Medroxyprogesterone, Dysfunctional family, Gynecology, Endometrium